Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus

CXC Chemokine Ligand 12 Promotes CCR7-Dependent Naive T Cell Trafficking to Lymph Nodes and Peyer's Patches

(2014) Z. Bai et al.   JOURNAL OF IMMUNOLOGY

Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

(2009) Douglas A. Stewart et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficient inhibition of SDF-1α-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists

(2009) Yuki Iwasaki et al.   CANCER SCIENCE

CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus

(2009) A. Wang et al.   JOURNAL OF IMMUNOLOGY

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

(2008) Frances Rena Bahjat et al.   ARTHRITIS AND RHEUMATISM

Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside

(2008) D. Wong et al.   CLINICAL CANCER RESEARCH

Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2008) D. S. Goodin et al.   NEUROLOGY